BRNS vs NOK · $38.2M cap vs P/E 87, $78.04B cap
Barinthus Biotherapeutics plc (BRNS) versus Nokia Corp ADR (NOK) — a side-by-side from cached financials, not a winner call.
Barinthus Biotherapeutics plc (BRNS) is a biotechnology company listed on US.
Nokia Corp ADR (NOK) is a communication equipment company listed on NYSE.
Latest reported BRNS revenue for 2025-09-30 was $0. Net income was -$14.6M. BRNS currently screens at market cap $38.2M.
NOK does not have a complete income-statement cache yet.
BRNS currently screens at market cap $38.2M. NOK currently screens at market cap $78.04B and trailing P/E 87.4.
Not investment advice. Open the BRNS and NOK stock pages for the full models.
Not investment advice.